Pegcetacoplan

Last Updated: 04/28/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 243 publications

Real-world Safety Profile of Avacincaptad Pegol in the Management of Geographic Atrophy.

Real-world Safety Profile of Avacincaptad Pegol in the Management of Geographic Atrophy.

Journal: Ophthalmic surgery, lasers & imaging retina
Published: March 27, 2026

Indirect treatment comparison of iptacopan versus pegcetacoplan for patients with paroxysmal nocturnal hemoglobinuria and residual anemia despite C5 inhibitor treatment.

Indirect treatment comparison of iptacopan versus pegcetacoplan for patients with paroxysmal nocturnal hemoglobinuria and residual anemia despite C5 inhibitor treatment.

Journal: Journal of comparative effectiveness research
Published: March 19, 2026

Pegcetacoplan in C3 Glomerulopathy and Immune-Complex MPGN.

Pegcetacoplan in C3 Glomerulopathy and Immune-Complex MPGN.

Journal: The New England journal of medicine
Published: March 11, 2026

Pegcetacoplan in C3 Glomerulopathy and Immune-Complex MPGN. Reply.

Pegcetacoplan in C3 Glomerulopathy and Immune-Complex MPGN. Reply.

Journal: The New England journal of medicine
Published: March 11, 2026

Drug-Related Uveitis: A Real-World Study Based on the Food and Drug Administration Adverse Event Reporting System Database.

Drug-Related Uveitis: A Real-World Study Based on the Food and Drug Administration Adverse Event Reporting System Database.

Journal: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics
Published: February 24, 2026

Complement 3 Glomerulopathy Revisited: Bridging Pathogenesis and Therapy in the New Era.

Complement 3 Glomerulopathy Revisited: Bridging Pathogenesis and Therapy in the New Era.

Journal: Advances in kidney disease and health
Published: February 11, 2026

Switching patients with PNH from pegcetacoplan to iptacopan: a case series.

Switching patients with PNH from pegcetacoplan to iptacopan: a case series.

Journal: Hematology (Amsterdam, Netherlands)
Published: February 09, 2026

Practical Considerations for Infection Prevention with the Clinical Use of Complement Inhibitors.

Practical Considerations for Infection Prevention with the Clinical Use of Complement Inhibitors.

Journal: Clinical journal of the American Society of Nephrology : CJASN
Published: February 06, 2026

Deep learning in geographic atrophy: rethinking age-related macular degeneration progression and treatment.

Deep learning in geographic atrophy: rethinking age-related macular degeneration progression and treatment.

Journal: Annals of translational medicine
Published: January 31, 2026

Ophthalmology : what's new in 2025

Ophthalmology : what's new in 2025

Journal: Revue medicale suisse
Published: January 22, 2026

Advancing treatment goals for paroxysmal nocturnal hemoglobinuria to align with quality of life improvements in the era of anti-complement therapy

Advancing treatment goals for paroxysmal nocturnal hemoglobinuria to align with quality of life improvements in the era of anti-complement therapy

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: January 12, 2026

Real-world clinical outcomes and treatment response in complement inhibitor experienced and naïve PNH patients prescribed pegcetacoplan in Europe and Canada.

Real-world clinical outcomes and treatment response in complement inhibitor experienced and naïve PNH patients prescribed pegcetacoplan in Europe and Canada.

Journal: Hematology (Amsterdam, Netherlands)
Published: January 02, 2026
Showing 1-12 of 243

Last Updated: 04/28/2026